## # ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||||||Unrestricted|Funds|Total|Total| |---|---|---|---|---|---|---|---|---| |||||Note|General|Other|2021|2020| |Income:|||||f,|||| |Awards
and donations|||||3,327||3,327|2,209| |Activities for generating
funds|||||172,560||172,560|267,189| |Investment
income|&bank|interest|||6,979||6,979|11,664| ||||||182,866||182,866|28],062| |Income from charitable
activities||||7|244,250||244,250|334,633| |Other income:||||||||| |Government
Grant|re Rental|Income|||137,683||137,683|| |Government
Job Retention||Scheme|||66,522||66,522|| ||||||204,205||204,205|| |Total income|||||631,321||631,321|615,695| |Expenditure||||||||| |Cost ofgenerating|funds|||8|290,748||290,748|388,318| |Costs ofcharitable|activities|||9|304,295||304,295|317,916| |Support costs||||10|208,483||208,483|219,563| |Total resources expended|||||803,526||803,526|925,797| |Net (expenditure)
for the year|||before|||||| |transfers
and other|recognised||gains/(losses)||(172,205)||(172,205)|(310,102)| |Gain on revaluation|—property|||13b|231,000||231,000|| |Profit on disposal ofPearsall Building||||13a|236,042||236,042|| |Profit on disposal —E Stoke Fishery||||||||246,461| |Net gain
/ (loss) on|investments||—quoted|13c|37,605||37,605|(47,249)| |Impairment
adjustment
ofRiver Lab||||13a|(403,437)||(403,437)|| |Net movement
of|funds
in|year|||(70,995)||(70&995)|(110,890)| |Reconciliation
offunds||||||||| |Total funds brought|forward|2020|||3,390,406|14,344|3,404,750|3,515,640| |Total funds carried|forward|2021|||3,319,411|14,344|3,333,755|3,340,750| ## ||||Note|2021|2020| |---|---|---|---|---|---| |Fixed Assets|||||| |Tangible|||13a|763,714|1,928,418| |Investments —Property|||13b|1,386,000|1,155,000| |Investments —Quoted|||13c|291,495|251,230| |||||2,441,209|3,334,648| |Current
Assets|||||| |Debtors and Prepayments|||14|146,495|126,616| |Investments —Cash held as part ofportfolio|||13c|660,132|12,792| |Cash at Bank and in Hand||||450,078|45,885| |||||1,256,705|185,293| |Less Current Liabilities|||||| |Creditors (due within|1 year)||15|(329,339)|(80,676)| |Net Current Assets||||927,366|104,617| |Total Assets Less Current||Liabilities||3,368,575|3,439,265| |Provision for Liabilities|||||| |Pension Provision|||22|(34,820)|(34,515)| |||||83,333,755|f.3,404,750| |Representing
Members'||Funds|||| |Unrestricted|||||| |General Fund|||16|3,319,411|3,050,161| |Designated
Furuls|||17|14,344|14,344| |Revaluation
Reserve|||18||340,245| |||||i3,333,755|83,404,750| ## ||||||2021||2020| |---|---|---|---|---|---|---|---| |Net cash used in operating
activities|||(See below)||65,425||(270,896)| |Cash flow from investing
activities:|||||||| |Investment
income|||||6,979||11,664| |Proceeds from sale/(purchase)|offixed assets||||981,789||296,067| |Amounts
(deposited)/withdrawn||from investments|||(650,000)||(15,000)| |Change
in cash and cash equivalent|||in the year||404,193||21,835| |Cash and cash equivalent
brought||forward|||45,885||24,050| |Cash and cash equivalent
carried||forward||f|450,078||K45,885| |Reconciliation ofnet movement||in|funds to net cash flow from operating|activities|||| ||||||2021||2020| |Net movement
in funds|||||(70,995)||(110,890)| |Add back depreciation
charge|||||15,825||54,439| |Deduct Investment
Income|||||(6,979)||(11,664)| |Deduct (gains)/add
back losses|on disposals &revaluations|||(101,210)|||(199,212)| |(Increase)/decrease
in debtors|||||(19,879)|.|48,815| |Increase/(decrease)
in creditors|||||248,663||(52,384)| |Net cash used in operating
activities|||||665,425||6(270,896)| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||This is sta|ted after charging:|||||||| |---|---|---|---|---|---|---|---|---|---| |||||||||2021|2020| ||Depreciation|||||||15,825|54,439| ||Profit|/ (loss) on disposal offixed assets||||||236,042|246,461| ||Auditors'
remuneration|||||||6,000|5,500| ||||||Unrestricted|Funds|||| ||||||General||Other|2021|2020| ||||||||6||| |4.|Awards|and Donations|||||||| ||Membership
donations||||1,200|||1,200|567| ||Legacies|and other donations|||2,127|||2,127|1,642| ||||||3,327|||3,327|2,209| |5.|Activities|for generating|funds||||||| ||Land and|building
income:|||||||| ||Windermere
(inc. annexe)||||87,100|||87,100|159,959| ||East|Stoke|||84,976|||84,976|99,168| ||Miscellaneous
income||||484|||484|8,062| ||||||172,560|||172,560|267,189| |6.|Investment
income||||||||| ||Investment|Income|||6,979|||6,979|11,664| ||||||6,979|||6,979|11,664| |7.|Charitable
activities||||||||| ||Membership
services||||19,762|||19,762|20,642| ||Scientific|and special publications|||11,498|||11,498|11,958| ||Research|contracts|||18,233|||18,233|50,314| ||Scientific|research &activity, direct funding|||||||| ||and grants||||188,744|||188,744|223,242| ||FBA Library/Data
&Information|||Services|7,451|||7,451|5,492| ||Training|courses and meetings|||(1,438)|||(1,43 8)|22,985| ||||||244,250|||244,250|334,633| ## |lltilEd
M|lltilEd
M||||Unrestricted
General|Funds
Other|2021|2020| |---|---|---|---|---|---|---|---|---| |S.|Cost ofgenerating|funds||||||| ||Land and buildings:|||||||| ||Windermere||||225,607||225,607|251,176| ||East Stoke||||65,141||65,141|134,142| ||||||290,748||290,748|388,318| |9.|Cost ofcharitable|activities||||||| ||Membership
services||||32,157||32,157|30,392| ||Scientific and special||publications||28,145||28,145|38,873| ||Research Contracts|||||||15,634| ||Scientific research|activity, direct||funding||||| ||and grants||||241,270||241,270|164,432| ||FBA Library/Data|&|Information|Services|2,301||2,301|57,198| ||Training
courses and||meetings||422||422|9,418| ||Redundancy
Costs|and fees||||||1,969| ||||||304,295||304,295|317,916| |10.|Support Costs|||||||| ||Council meetings
and||reimbursements|||||| ||to Trustees||||598||598|2,597| ||Other costs —direct|and indirect:||||||| ||Audit fees||||6,000||6,000|5,500| ||Other professional||fees||24,324||24,324|24,112| ||Staff costs||||108,082||108,082|134,189| ||Redundancy
Costs||and fees|||||5,906| ||Irrecoverable
VAT|||||||(2,652)| ||IT support &other||office costs||69,479||69,479|49,911| ||||||208,483||208,483|219,563| ## |Average nu|mber of|employees
was|12(9FTE)paid employees (|2020: 15(12FTE))|| |---|---|---|---|---|---| |Total Staff|Costs in|the year were;||2021|2020| |||||8|| |Salaries||||316,351|370,078| |Employer's|National|Insurance
Contributions||25,421|30,606| |Employer's|Pension|contributions|(Note 23)|22,331|22,246| |Employer's|Pension|Provision (Note 23)||305|822| |Total (including
redundanoy
costs|||of$7,875 in 2020)|364,408|423,752| ## ## ## |(a)|~Tan
ibis|||||| |---|---|---|---|---|---|---| |||Freehold Land &|Plant &|~Com
uter|Scientific|| |||~Buildin
s|~Mach(ncr|and other|~EI IIIel t|Total| |||||E~ut
ment||| ||Cost or Valuation|||||| ||At 1st April 2020|1,740,004|348,156|199,506|26,034|2,313,700| ||Additions|||5,590||5,590| ||Disposals|(500,000)|(348,156)|(147,360)|(26,034)|(1,021,550)| ||Impairment
adjustment|(465,657)||||(465,657)| ||At 31stMarch 2021|774,347||57,736||832,083| ||Accumulated
De rectation|||||| ||As at 1st April 2020|103,255|69,524|186,469|26,034|385,282| ||Charge for the year|2,789||13,036||15,825| ||Disposals|(27,600)|(69,524)|(147,360)|(26,034)|(270,518)| ||Impairment
adjustment|(62,220)||||(62,220)| ||At 31stMarch 2021|16,224||52,145||68,369| ||Net book value|||||| ||At 31stMarch 2021|758,123||5,591||763,714| ||At 31stMarch 2020|1,636,749|278,632|13,037|external|1,928,418| ## ## ## |Quoted investments
are valued|Quoted investments
are valued|in accordance with their UK Stock Exchange|listings at the balance sheet dates,| |---|---|---|---| ||||Quoted| ||||Investments| |Market Value|at 1stApril 2020||264,022| |Additions/(Disposals)|||650,000| |Net Investment|gains to General|Fund Account (Note 16)|37,605| |Market Value|at 31stMarch 2021||951,627| ||Represented
by:|||||||| |---|---|---|---|---|---|---|---|---| ||Investments
held on UK Stock Exchange|||||||291,495| ||Cash held as part ofPortfolio|||||||660,132| |||||||||951,627| |14.|Debtors||||||2021|2020| ||Trade Debtors||||||89,074|74,284| ||Other Debtors||||||57,421|52,332| ||||||||146,495|126,616| |15.|Creditors|||||||| ||PAVE, MC and pension||||||11,287|8,821| ||Trade Creditors||||||81,953|25,238| ||Other Creditors
and Accruals||||||38,304|15,352| ||Deferred income|||||||17,806| ||VAT creditor||||||197,795|13,459| ||||||||329,339|80,676| |16.|General Fund Account||||||2021|2020| ||General Fund Account|||||||6| ||Balance brought
forward||||||3,050,161|3,164,619| ||Net movement
in funds|before||transfers|and|||| ||other recognised
gains||||||(172,205)|(310,102)| ||||||||2,877,956|3,854,517| ||Transfer net movement|to Other Funds|||(Notes 4to 10)|||(9,304)| ||Unrealised
gain on revaluation|||ofproperty||(Note 13b)|231,000|| ||Unrealised
gain
/ (loss)|arising||from revaluation||||| ||ofInvestments
(Note 13c)||||||37,605|(47,249)| ||Realised gain on sale ofproperty||||||236,042|246,461| ||Transfer from Revaluation||Reserve re||Pearsall (Note 18)||163,525|5,736| ||Transfer from Revaluation||Reserve re River Lab (Note 18)||||176,720|| ||Impairment
adjustment|(Note 13a)|||||(403,437)|| ||Transfer between Funds|(Note||17)||||| ||||||||3,319,411|3,050,161| ## ## ||The balances ofthese fu|nds are included|withi|n the Balance Sheet Net Asse|ts as Cash at Bank and i| |---|---|---|---|---|---| |18.|Revaluation
Reserve||||| ||Balance brought
forward|at 01.04.2020|||340,245| ||Adjustment
on sale ofRiver Laboratory||in 2021/22||(176,720)| ||Transfer to general
fund|—remove revaluation||reserve on the|| ||disposal ofthe Pearsall|building|||(163,525)| ||Balance carried forward|at31.03.2021|||| ## ## ## ## ## |Pension increases|(CPI)|(CPI)||Term dependent|rates in line with|rates in line with|the|the|difference between|difference between|difference between|the||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||||Fixed Interest and Index Linked yield|||||curves, less 1.3%p.a.|||||| |Discount Rate (forward||||Years 1-10:CPI|—0.14%reducing|||linearly||to CPI —0.73%||||| |rates)||||Years 11-20:CPI+ 2.52%reducing||||linearly||to CPI+|1.55% by year 21|||| |||||Years 21+:CPI + 1.55%||||||||||| |The main demographic||assumption|used relates to the mortality
assumptions.||||These assumptions||||are|based on analysis||| |ofthe Scheme's|experience
carried out as part ofthe 2018 actuarial|||||valuation.|||The|mortality|assumptions||used|in| |these figures are|as follows:|||||||||||||| |||2018Valuation||||||||||||| |Mortality
base table||Pre-retirement:|||||||Post retirement:|||||| |||71%ofAMC00 (duration
0)for males and||||112%|||97.6%ofSAPS||SINMA "light" for|||| |||ofAFC00|(duration 0)for females.||||||males|and 102.7%||ofRFV00||| ||||||||||for females.|||||| |Future improvements||CMI 2017with a smoothing
parameter of8.5||||||||||||| |to mortality||and a long|term improvement
rate||of1.8%pa|||||||||| |||for males and 1.6%for females.||||||||||||| |The current life expectancies
on retirement||||at age 65 are:||||||||||| |||||||2018Valuation||||2017|Valuation|||| |Males currently
aged 65 (years)|||||||||24.4|||24.6||| |Females currently|aged|65 (years)|||||||25.9|||26.I||| |Males currently
aged 45 (years)|||||||||26.3|||26.6||| |Females currently|aged|45 (years)|||||||27.7|||27.9||| ## ## ## ## ## ## ## ## ## ## ##